First Allied Advisory Services’s Thermo Fisher Scientific TMO Stock Holding History

First Allied Advisory Services’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$3.18M	Buy	7,202 +219	+3%	+$90.5K	0.11%	202
2020 Q2	$2.53M	Buy	6,983 +186	+3%	+$62.3K	0.09%	230
2020 Q1	$1.93M	Buy	6,797 +411	+6%	+$130K	0.08%	248
2019 Q4	$2.07M	Sell	6,386 -67	-1%	-$20.3K	0.07%	307
2019 Q3	$1.87M	Buy	6,453 +494	+8%	+$141K	0.07%	321
2019 Q2	$1.75M	Sell	5,959 -333	-5%	-$91.7K	0.06%	326
2019 Q1	$1.72M	Buy	6,292 +481	+8%	+$120K	0.06%	324
2018 Q4	$1.3M	Sell	5,811 -117	-2%	-$27.5K	0.05%	354
2018 Q3	$1.44M	Buy	5,928 +1,089	+23%	+$251K	0.05%	365
2018 Q2	$998K	Buy	4,839 +403	+9%	+$85.5K	0.04%	454
2018 Q1	$910K	Buy	4,436 +10	+0.2%	+$2.1K	0.04%	473
2017 Q4	$842K	Buy	4,426 +159	+4%	+$30.5K	0.03%	492
2017 Q3	$812K	Buy	4,267 +35	+0.8%	+$6.34K	0.04%	469
2017 Q2	$735K	Buy	4,232 +391	+10%	+$65.7K	0.03%	507
2017 Q1	$594K	Sell	3,841 -302	-7%	-$46.2K	0.03%	525
2016 Q4	$585K	Buy	4,143 +743	+22%	+$110K	0.03%	532
2016 Q3	$541K	Sell	3,400 -749	-18%	-$115K	0.03%	540
2016 Q2	$618K	Sell	4,149 -578	-12%	-$85.3K	0.03%	484
2016 Q1	$674K	Sell	4,727 -460	-9%	-$61.6K	0.04%	462
2015 Q4	$737K	Buy	5,187 +41	+0.8%	+$5.47K	0.04%	450
2015 Q3	$620K	Sell	5,146 -2,614	-34%	-$341K	0.03%	498
2015 Q2	$1.01M	Buy	7,760 +162	+2%	+$21.1K	0.05%	397
2015 Q1	$1.02M	Buy	7,598 +2,378	+46%	+$307K	0.07%	346
2014 Q4	$660K	Buy	5,220 +317	+6%	+$38.5K	0.05%	441
2014 Q3	$589K	Buy	4,903 +97	+2%	+$11.8K	0.05%	454
2014 Q2	$566K	Sell	4,806 -665	-12%	-$78.3K	0.04%	482
2014 Q1	$656K	Sell	5,471 -1,353	-20%	-$161K	0.05%	432
2013 Q4	$756K	Buy	6,824 +629	+10%	+$62.5K	0.06%	374
2013 Q3	$568K	Buy	6,195 +1,541	+33%	+$139K	0.03%	480
2013 Q2	$390K	Buy	+4,654	New	+$387K	0.03%	580

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

First Allied Advisory Services's TMO Position: Q3 2020 in Review

First Allied Advisory Services increased its Thermo Fisher Scientific (TMO) stake by 3.1% in Q3 2020, buying an estimated $90.5K and bringing the position to 7,202 shares worth $3.18M. The position accounts for 0.11% of the portfolio, ranked #202.

First Allied Advisory Services first reported a position in TMO in Q2 2013 and has held it in 30 quarters since. 1,847 funds tracked by Wall St. Rank hold TMO as of Q3 2020.

First Allied Advisory Services held 7,202 shares of Thermo Fisher Scientific worth $3.18M as of Q3 2020.
First Allied Advisory Services bought 219 Thermo Fisher Scientific shares in Q3 2020, an estimated $90.5K.
Thermo Fisher Scientific made up 0.11% of First Allied Advisory Services's portfolio in Q3 2020, its #202 holding.
First Allied Advisory Services first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 30 quarters since.
1,847 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2020.

Based on First Allied Advisory Services's 13F filing for Q3 2020, filed 13 Nov 2020.